We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Product recall for Vichy Liftactiv Specialist Peptide-C Anti-Aging-Ampullen presenting a risk of injuries.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
Product Safety Report for Stay Young Face & Body Cream sold via eBay presenting a serious chemical risk.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Product recall for Stay Young Skin Lightening Cream with Cocoa Butter and Vitamin E presenting a serious risk to health due to the presence of the prohibited substances.
Product Safety Report for GDK Akagni Skin Toning Cream presenting a serious chemical risk.
Product Safety Report for Anise Shealight Fading Cream Face & Body presenting a serious chemical risk.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Check what you need to do to sell cosmetic products in Great Britain.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Importing investigational medicinal products for use in clinical trials
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Product recall for Firming Cream presenting a serious chemical risk.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).